RRJ5

Reference:

Parker-Pope, T. (2010, April 28). Clue for personalizing breast cancer treatment.

The New York Times, Retrieved May 3, 2010, from http://well.blogs.nytimes.com/2010/04/28/clues-for-personalizing-breast-cancer-treatment/

Summary:

There is a new study to offer a clue to understand whether a patient needs aggressive treatment on the early stage of breast cancer. Therefore, the patient does not take unnecessary treatment. The researcher of the University of California confirmed three specific “biomakers” which predicted the danger of the invasive cancer. Most patients have to choose

a combination of lumpectomy and radiation or mastectomy. With these marks, the study will decrease overtreatment and it may be possible for individualized cancer treatment.

Reaction:

It is a very important thing that women discover the early breast cancer and treat it early. In current cancer treatment, aggressive treatment is common. If the new study is taken under inspection, we can reduce overtreatment. Besides, women can take the personalized breast cancer treatment. I think that there is enough room for still more improvement on the treatment of cancer. It is necessary for the woman with breast cancer to know expanse of the condition of the invasive cancer in precision before losing their breast. Before treatment, I think that we should develop inspection to know the progress of the cancer more. The current cancer treatment does not completely allow us to understand the progress of the invasive cancer, unless it appears after excision.

RRJ4

Reference:

Neergaard, L. (2010, April 26). Dirty-Bomb Test for Terror May Aid Cancer Research.

The New York Times, Retrieved April 27, 2010, from http://www.nytimes.com/aponline/2010/04/26/health/AP-US-MED-HealthBeat-Radiation-Test.

Summary:

Scientists found that a method can distinguish the person who is exposed to radiation from another quickly. The research might use the treatment of cancer. The government has to prepare against a terrorist attack, vaccines and chemical threats. Radiological threat is one of these. Lymphocytes, which are immune cells, are very sensitive to radiation and change the response of genes. Duke hematology specialist Dr. John Chute found the response of genes with two or three drops of blood. He has to change the find into an emergency test.

Reaction:

Nowadays, there is no way to distinguish the people who are exposed to radiation from other people quickly. I think some test which has a purpose often aids other research. If radioactive contamination happened, we would not find the situation visually soon. I did not know lymphocytes are super-sensitive to radiation. I know the genes switch on and off in response to radiation. I am interested in the relation between genes and radiation.